JAK inhibitor updates in Alopecia Areata

Research into JAK inhibitors as a treatment for alopecia areata continues and we have now seen the first peer reviewed publication of a placebo controlled trial for the drug Baricitinib, showing response rates of over 50% achieving an improvement to less than 20%...

Changes to Services 2021

So far, 2021 has been really busy in the private sector for dermatology. There is no doubt this is in part due to Covid, with difficulty for patients getting to see their own doctor and longer than normal waits in the NHS. Locally in the NHS, the average wait for a...

Seeing the Right Person – First Time!

The past year has seen a shift in how patients access healthcare. With limited access to GPs and challenges in getting seen and referred to NHS specialist care, more patients are choosing to take matters into their own hands and self refer for private healthcare. But...

New Virtual Dermatology Course for GPs 2021

This Thursday I will be starting the first of monthly education sessions aimed at GPs. This is following on from the successful Mole Hill series I ran during the first lock down last May. Instead of weekly sessions, we will be hosting these talks on a monthly basis...

Reflections on 2020

As we reach the end of the year it is a good time to look back and reflect on a year like no other. It’s hard to believe that twelve months ago none of us had heard of Covid, Zoom, social distancing and lockdowns. NHS services have had to radically change and...